Skip to main content
SpringerLink
Log in

The greater impact of menopause on ER– than ER+ breast cancer incidence: a possible explanation (United States)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: Analysis of 3359 Danish breast cancer cases indicated that menopause exerted a greater protective effect on estrogen- receptor negative (ER–) breast cancer than on estrogen- receptor positive (ER+) breast cancer. We examined US age-specific breast cancer rates by hormone receptor status in white and black women and men to investigate this unexpected result. Methods: Age-specific breast cancer incidence rates from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute were analyzed by joint estrogen receptor and progesterone receptor (ER/PR) status of 101,140 white female and 8870 black female cases and by ER status in 706 white male and black male cases diagnosed from 1992 to 1998. Changes in the rate of increase in rates with age were identified using Poisson regression analyses. Results: For both white women and black women the age-specific rates of ER– breast cancer cease increasing after 50 years of age, but age-specific rates of ER+ breast cancer continue to increase after 50 years of age. For men the incidence of ER– cancers may increase at a slower rate than incidence of ER+ cancers in older ages. In women the black rates of ER+ cancers are greater than white rates only until age 35, but black rates of ER– cancers are greater than white rates for all ages. Conclusions: Differences in age-specific breast cancer incidence patterns by hormone receptor status are similar for black women and white women. The incidence pattern for ER– cancers is consistent with a paracrine model for hormone-stimulated growth in normal breast tissue. The continued increase in ER+ cancers after menopause may be explained by both the paracrine growth model and an increase in the proliferation rate of ER+ cells with age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yasui Y, Potter JD (1999) The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 10: 431-437.

    Google Scholar 

  2. SEER (2001) SEER*Stat, ed (4.0). Cancer incidence public-use database, 1973-1998, August 2000 submission. Bethesda, MD: National Cancer Institute.

  3. Fritz A, Ries L (1998) The SEER Program Code Manual, 3rd edn. Bethesda, MD: National Cancer Institute, NIH Publication No. 99-2313.

  4. Gustafsson J-A, Warner M (2000) Estrogen receptor b in the breast: role in estrogen responsiveness and development of breast cancer. Steroid Biochem Mol Biol 74: 245-248.

    Google Scholar 

  5. MacMahon B (1958) Cohort fertility and increasing breast cancer incidence. Cancer 11: 250-254.

    Google Scholar 

  6. Stevens RG, Moolgavkar SH, Lee JA (1982) Temporal trends in breast cancer. Am J Epidemiol 115: 759-777.

    Google Scholar 

  7. Tarone RE, Chu KC (1992) Implications of birth cohort patterns in population disease rates. J Natl Cancer Inst 84: 1402-1410.

    Google Scholar 

  8. Tarone RE, Chu KC (1996) Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 143: 85-91.

    Google Scholar 

  9. McCullagh P, Nelder JA (1989) Generalized Linear Models, 2nd edn. London: Chapman & Hall.

    Google Scholar 

  10. Petersen OW, Hoyer PE, van Deurs B (1987) Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47: 5748-5751.

    Google Scholar 

  11. Jacquemier JD, Hassoun J, Torrente M, Martin P-M (1990) Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages-immunohistochemical study of 107 cases. Breast Cancer Res Treat 15: 109-117.

    Google Scholar 

  12. Ricketts D, Turnbull L, Ryall G, et al. (1991) Estrogen and progesterone receptors in the normal female breast. Cancer Res 51: 1817-1822.

    Google Scholar 

  13. Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP (1999) Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 188: 237-244.

    Google Scholar 

  14. Shoker BS, Jarvis C, Clarke RB, et al. (1999) Estrogen receptorpositive proliferating cells in the normal and precancerous breast. Am J Pathol 155: 1811-1815.

    Google Scholar 

  15. Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991.

    Google Scholar 

  16. Russo J, Ao X, Grill C, Russo IH (1999) Pattern of distribution of cells positive for estrogen receptor a and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53: 217-227.

    Google Scholar 

  17. Anderson E, Clarke RB, Howell A (1998) Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 3: 23-35.

    Google Scholar 

  18. Russo J, Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11: 169-178.

    Google Scholar 

  19. Khan SA (1995) Estrogen and progesterone receptors in benign breast epithelium. Breast J 4: 251-261.

    Google Scholar 

  20. Nicholson RI, Bouzubar N, Walker KJ, et al. (1991) Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. Eur J Cancer 127: 908-913.

    Google Scholar 

  21. Perou CM, Sørlie T, Eisen MB, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.

    Google Scholar 

  22. Moolgavkar SH (1986) Hormones and multistage carcinogenesis. Cancer Surv 5: 635-648.

    Google Scholar 

  23. Israel L, Band P (1984) Hormones as cancer growth factors. Lancet 2: 843-844.

    Google Scholar 

  24. Walker KJ, McClelland RA, Candlish W, Blamey RW, Nicholson RI (1992) Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. Eur J Cancer 28: 34-37.

    Google Scholar 

  25. Khan SA, Rogers MAM, Khurana KK, Meguid MM, Numann PJ (1997) Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 89: 37-42.

    Google Scholar 

  26. Shoker BS, Jarvis C, Clarke RB, et al. (2000) Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol 53: 778-783.

    Google Scholar 

  27. Iqbal M, Davies MPA, Shoker BS, Jarvis C, Sibson DR, Sloane JP (2001) Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells. J Pathol 193: 333-338.

    Google Scholar 

  28. Ballare C, Bravo AI, Laucella S, et al. (1989) DNA synthesis in estrogen receptor-positive human breast cancer takes place preferentially in estrogen receptor-negative cells. Cancer 64: 842-848.

    Google Scholar 

  29. Netto GJ, Cheek JH, Nannepaga YZ, et al. (1990) Steroid receptors in benign mastectomy tissue. Am J Clin Pathol 94: 14-17.

    Google Scholar 

  30. Khan SA, Rogers MAM, Obando JA, Tamsen A (1994) Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 54: 993-997.

    Google Scholar 

  31. Boyd MT, Hildebrandt RH, Bartow SA (1996) Expression of the estrogen gene in developing and adult human breast. Breast Cancer Res Treat 37: 243-251.

    Google Scholar 

  32. Bartow SA (1998) Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast. J Mammary Gland Biol Neoplasia 3: 37-48.

    Google Scholar 

  33. Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D (1999) Low oestrogen receptor a expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 354: 1787-1788.

    Google Scholar 

  34. Nomura Y, Kobayashi S, Takatani O, Sugano H, Matsumoto K, McGuire WL (1977) Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res 37: 106-110.

    Google Scholar 

  35. Nomura Y, Miura S, Koyama H, et al. (1992) Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. Cancer 69: 153-164.

    Google Scholar 

  36. van Agthoven T, Timmermans M, Foekens JA, Dorssers LCJ, Henzen-Logmans SC (1994) Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol 144: 1238-1246.

    Google Scholar 

  37. Cowan DF, Herbert TA (1989) Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. Surg Pathol 2: 323-333.

    Google Scholar 

  38. Henson DE, Tarone RE (1993) On the possible role of involution in the natural history of breast cancer. Cancer 71: 2154-2156.

    Google Scholar 

  39. Henson D, Tarone RE (1994) Involution and the etiology of breast cancer. Cancer 74: 424-429.

    Google Scholar 

  40. Hart BL, Steinbock RT, Mettler FA, Pathak DR, Bartow SA (1989) Age and race related changes in mammographic parenchymal patterns. Cancer 63: 2537-2539.

    Google Scholar 

  41. Robertson JFR (1996) Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5-12.

    Google Scholar 

  42. Hildreth NG, Kelsey JL, Eisenfeld AJ, LiVolsi VA, Holford TR, Fischer DB (1983) Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst 70: 1027-1031.

    Google Scholar 

  43. Hislop TG, Coldman AJ, Elwood JM, Skippen DH, Kan L (1986) Relationship between risk factors for breast cancer and hormonal status. Int J Epidemiol 15: 469-476.

    Google Scholar 

  44. McTiernan A, Thomas DB, Johnson LK, Roseman D (1986) Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst 77: 849-854.

    Google Scholar 

  45. Stanford JL, Szklo M, Boring CC, et al. (1987) A case-control study of breast cancer stratified by estrogen receptor status. Am J Epidemiol 125: 184-194.

    Google Scholar 

  46. Cooper JA, Rohan TE, Cant ELM, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 59: 119-125.

    Google Scholar 

  47. Kreiger N, King WD, Rosenberg L, Clarke EA, Palmer JR, Shapiro S (1991) Steroid receptor status and the epidemiology of breast cancer. Ann Epidemiol 1: 513-523.

    Google Scholar 

  48. Habel LA, Stanford JL (1993) Hormone receptors and breast cancer. Epidemiol Rev 15: 209-219.

    Google Scholar 

  49. Potter JD, Cerhan JR, Sellers TA, et al. (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4: 319-326.

    Google Scholar 

  50. Yoo KY, Tajima K, Miura S, et al. (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 146: 307-314.

    Google Scholar 

  51. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151: 703-714.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892, USA

    Robert E. Tarone

  2. Center to Reduce Cancer Health Disparities, National Cancer Institute, Bethesda, MD, 20892, USA

    Kenneth C. Chu

Authors
  1. Robert E. Tarone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth C. Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarone, R.E., Chu, K.C. The greater impact of menopause on ER– than ER+ breast cancer incidence: a possible explanation (United States). Cancer Causes Control 13, 7–14 (2002). https://doi.org/10.1023/A:1013960609008

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013960609008

Search

Navigation